Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the original ANDA for Levothyroxine Sodium from Zydus Pharmaceuticals USA Inc., expanding access to a generic thyroid hormone replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)